DK3242882T3 - Cgrp-antagonistpeptider - Google Patents

Cgrp-antagonistpeptider Download PDF

Info

Publication number
DK3242882T3
DK3242882T3 DK16700059.5T DK16700059T DK3242882T3 DK 3242882 T3 DK3242882 T3 DK 3242882T3 DK 16700059 T DK16700059 T DK 16700059T DK 3242882 T3 DK3242882 T3 DK 3242882T3
Authority
DK
Denmark
Prior art keywords
antagonistpeptider
cgrp
Prior art date
Application number
DK16700059.5T
Other languages
English (en)
Inventor
Kazimierz Wisniewski
Guangcheng Jiang
Aleksandr K Rabinovich
Javier J Sueiras-Diaz
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3242882T3 publication Critical patent/DK3242882T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
DK16700059.5T 2015-01-06 2016-01-06 Cgrp-antagonistpeptider DK3242882T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562100371P 2015-01-06 2015-01-06
PCT/EP2016/050110 WO2016110499A1 (en) 2015-01-06 2016-01-06 Cgrp antagonist peptides

Publications (1)

Publication Number Publication Date
DK3242882T3 true DK3242882T3 (en) 2022-08-08

Family

ID=55071041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16700059.5T DK3242882T3 (en) 2015-01-06 2016-01-06 Cgrp-antagonistpeptider

Country Status (34)

Country Link
US (1) US9969775B2 (da)
EP (1) EP3242882B1 (da)
JP (1) JP6929227B2 (da)
KR (1) KR20170102302A (da)
CN (1) CN107207567B (da)
AR (1) AR103499A1 (da)
AU (1) AU2016206059B2 (da)
BR (1) BR112017013413A2 (da)
CA (1) CA2973041A1 (da)
CL (1) CL2017001761A1 (da)
CO (1) CO2017007940A2 (da)
DK (1) DK3242882T3 (da)
EA (1) EA032082B1 (da)
ES (1) ES2924410T3 (da)
HR (1) HRP20220941T1 (da)
HU (1) HUE059379T2 (da)
IL (1) IL252903B (da)
JO (1) JO3669B1 (da)
LT (1) LT3242882T (da)
MA (1) MA41311B1 (da)
MD (1) MD3242882T2 (da)
MX (1) MX2017008893A (da)
MY (1) MY196439A (da)
PH (1) PH12017501214A1 (da)
PL (1) PL3242882T3 (da)
PT (1) PT3242882T (da)
RS (1) RS63467B1 (da)
SA (1) SA517381865B1 (da)
SG (1) SG11201705306UA (da)
SI (1) SI3242882T1 (da)
TN (1) TN2017000248A1 (da)
TW (1) TWI717331B (da)
UA (1) UA121490C2 (da)
WO (1) WO2016110499A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019087161A1 (en) * 2017-11-06 2019-05-09 Auckland Uniservices Limited Peptide conjugate cgrp receptor antagonists and methods of preparation and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268474B1 (en) * 1998-04-30 2001-07-31 Creighton University Peptide antagonists of CGRP-receptor superfamily and methods of use
TW200533398A (en) 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
CA2582593A1 (en) * 2004-10-07 2006-04-20 Merck & Co., Inc. Cgrp receptor antagonists
KR20070104355A (ko) * 2005-01-17 2007-10-25 제리니 아게 C5a 수용체 안타고니스트
JP2008533147A (ja) * 2005-03-14 2008-08-21 メルク エンド カムパニー インコーポレーテッド Cgrp受容体拮抗薬
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
PT2380592T (pt) * 2005-11-14 2018-06-06 Teva Pharmaceuticals Int Gmbh Anticorpos antagonistas dirigidos contra o péptido relacionado com o gene da calcitonina e métodos utilizando os mesmos
TW200813019A (en) * 2006-06-13 2008-03-16 Vertex Pharma CGRP receptor antagonists
KR101855242B1 (ko) * 2012-01-26 2018-05-09 크리스토퍼 제이. 소레스 펩타이드 호르몬의 칼시토닌 cgrp 패밀리의 펩타이드 길항제 및 그의 용도

Also Published As

Publication number Publication date
CL2017001761A1 (es) 2018-01-26
EP3242882A1 (en) 2017-11-15
RS63467B1 (sr) 2022-08-31
AU2016206059A1 (en) 2017-07-20
SI3242882T1 (sl) 2022-09-30
HRP20220941T1 (hr) 2022-10-28
ES2924410T3 (es) 2022-10-06
PL3242882T3 (pl) 2022-10-31
AU2016206059B2 (en) 2019-07-25
CN107207567B (zh) 2021-11-23
MY196439A (en) 2023-04-11
CO2017007940A2 (es) 2017-10-31
KR20170102302A (ko) 2017-09-08
SG11201705306UA (en) 2017-07-28
IL252903B (en) 2021-01-31
MD3242882T2 (ro) 2022-10-31
PT3242882T (pt) 2022-08-09
TN2017000248A1 (en) 2018-10-19
EP3242882B1 (en) 2022-05-04
SA517381865B1 (ar) 2021-09-15
LT3242882T (lt) 2022-08-25
JO3669B1 (ar) 2020-08-27
US9969775B2 (en) 2018-05-15
EA201791456A1 (ru) 2018-01-31
BR112017013413A2 (pt) 2018-01-09
HUE059379T2 (hu) 2022-11-28
TW201630929A (zh) 2016-09-01
MA41311A (fr) 2017-11-14
MA41311B1 (fr) 2022-10-31
MX2017008893A (es) 2017-10-25
TWI717331B (zh) 2021-02-01
WO2016110499A1 (en) 2016-07-14
JP6929227B2 (ja) 2021-09-01
CA2973041A1 (en) 2016-07-14
AR103499A1 (es) 2017-05-17
US20180002378A1 (en) 2018-01-04
PH12017501214A1 (en) 2018-01-08
IL252903A0 (en) 2017-08-31
CN107207567A (zh) 2017-09-26
UA121490C2 (uk) 2020-06-10
JP2018505213A (ja) 2018-02-22
EA032082B1 (ru) 2019-04-30

Similar Documents

Publication Publication Date Title
DK3389557T3 (en) Transseptalt leveringssystem
DK3320033T3 (en) Polyethylenterephthalat-depolymerisering
DK3256579T3 (en) Cysteinprotease
DK3256580T3 (en) Cysteinprotease
DK3298030T3 (en) Anti-cancerfusionspolypeptid
DK3250592T3 (en) Anti-transthyretin-antistoffer
DK3373882T3 (en) Patientisolator
DK3284069T3 (en) Pos-terminal
GB201500806D0 (en) Aerosol-gnerating aticle
DK3390996T3 (en) Trykbart tids-temperaturindikatorsystem
DK3380145T3 (en) Injektionsapparat
DK3336185T3 (en) Antistof
DK3272750T3 (en) Morphinan-derivat
GB201501723D0 (en) Winics
DK3324768T3 (en) Tørdragt
AU361999S (en) Ballustrade
DK3133099T3 (en) Polymermodificeret polyoldispersion
DK3282866T3 (en) Proteinfibre
DK3250312T3 (en) Urea-metalnitrat-scr-system
DK3294653T3 (en) Justerbar inline-port
DK3242882T3 (en) Cgrp-antagonistpeptider
AU5516P (en) LEP08 Lepidosperma squamatum
AU5511P (en) PTK647 Epichloe coenophiala
AU366552S (en) Nutblock
GB201520593D0 (en) Easyhinge